135 related articles for article (PubMed ID: 11876588)
1. Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis.
Kawata R; Shimada T; Maruyama S; Hisa Y; Takenaka H; Murakami Y
Acta Otolaryngol; 2002 Jan; 122(1):101-6. PubMed ID: 11876588
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistological investigation of type IV collagen in the basement membrane surrounding the cancer nest (cancer nest membrane) of head and neck squamous cell carcinoma--its relation to frequency of cervical lymph node metastasis].
Murakami M; Mimaki S; Saitou Y; Wada Y; Nishiyama Y; Yasuda N; Murakami Y
Nihon Jibiinkoka Gakkai Kaiho; 1992 Nov; 95(11):1773-84. PubMed ID: 1464793
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
Do NY; Lim SC; Im TS
Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
[TBL] [Abstract][Full Text] [Related]
4. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
[TBL] [Abstract][Full Text] [Related]
5. [Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis].
Kondakova IV; Klisho EV; savenkova OV; Kakurina GV; Choĭnzonov EL; Shishkin DA; Mukhamedov MP
Biomed Khim; 2008; 54(5):555-60. PubMed ID: 19105397
[TBL] [Abstract][Full Text] [Related]
6. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase-12 is correlated with extracapsular spread of tumor from nodes with metastasis in head and neck squamous cell carcinoma.
Kim JM; Kim HJ; Koo BS; Rha KS; Yoon YH
Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):1137-42. PubMed ID: 22907031
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
Riedel F; Götte K; Schwalb J; Hörmann K
Anticancer Res; 2000; 20(5A):3045-9. PubMed ID: 11062721
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
12. Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue.
Zhou CX; Gao Y; Johnson NW; Gao J
Aust Dent J; 2010 Dec; 55(4):385-9. PubMed ID: 21174909
[TBL] [Abstract][Full Text] [Related]
13. Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma--tissue immunoreactivity predicts aggressive clinical course.
Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
Mod Pathol; 2006 Feb; 19(2):208-17. PubMed ID: 16424893
[TBL] [Abstract][Full Text] [Related]
14. [Matrix metalloproteinase-2 concentrations in squamous cell carcinoma of the head and neck and its clinical significance].
Kawata R; Shinomiya T; Yasuda N; Takenaka H; Murakami Y
Nihon Jibiinkoka Gakkai Kaiho; 1996 Feb; 99(2):299-305. PubMed ID: 8851335
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck].
Al Kassam D; Alvarez Marcos C; Blanco I; de Los Toyos JR; Llorente JL
Med Clin (Barc); 2007 Dec; 129(20):761-5. PubMed ID: 18093475
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study.
Kusukawa J; Sasaguri Y; Shima I; Kameyama T; Morimatsu M
Am J Clin Pathol; 1993 Jan; 99(1):18-23. PubMed ID: 8422010
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C
Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993
[TBL] [Abstract][Full Text] [Related]
19. [Expression of matrix metalloproteinase-2,9 in hypopharyngeal carcinoma and its relationship with lymphatic metastasis].
Li Q; Li X; Yao L
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 18(6):324-6. PubMed ID: 15354768
[TBL] [Abstract][Full Text] [Related]
20. Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma.
Huang T; Chen MH; Wu MY; Wu XY
Ann Otol Rhinol Laryngol; 2013 Mar; 122(3):210-5. PubMed ID: 23577575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]